103例甲状腺微小乳头状癌中央淋巴结转移的预测因素分析
Analysis of Predictive Factors for Central Lymph Node Metastasis in 103 Cases of Micropapillary Thyroid Carcinoma
摘要: 目的:回顾性研究甲状腺微小乳头状癌(papillary thyroid microcarcinoma, PTMC)发生中央区淋巴结转移(Central lymph node metastasis, CLNM)的影响因素。方法:收集2019年12月至2022年12月期间就诊于乌鲁木齐市中医院并经病理诊断为PTMC的患者103例,分析其性别、年龄、民族、体重指数、TSH值、肿瘤直径、被膜侵犯、微钙化灶、癌灶数量、有无合并症与CLNM的相关性。结果:PTMC发生CLNM率为39.87% (41/103),经单因素分析,性别、年龄、肿瘤直径、微钙化灶及癌灶数量是PTMC发生CLNM的危险因素(P < 0.05);Logistic回归分析结果显示,性别、年龄、肿瘤直径、被膜侵犯以及多发癌灶是PTMC发生CLNM的危险因素(P < 0.05)。结论:可将性别、年龄、民族、体重指数、TSH值、肿瘤直径、被膜侵犯、微钙化灶、癌灶数量、有无合并症作为量化风险评估PTMC发生CLNM的预测因素,为进一步选择适合治疗方案提供参考。
Abstract: Objective: To retrospectively study the influencing factors of central lymph node metastasis (CLNM) in papillary thyroid microcarcinoma (PTMC). Methods: 103 patients who attended Urumqi Hospital of Traditional Chinese Medicine and were diagnosed as PTMC by pathology between December 2019 and December 2022 were collected, and the correlation between gender, age, ethnicity, body mass index, TSH value, tumor diameter, peritumoral invasion, microcalcified foci, the number of cancer foci, the presence of comorbidities and CLNM was analyzed. Results: The incidence of CLNM in PTMC was 39.87% (41/103), and by univariate analysis, gender, age, tumor diameter, microcalcified foci, and the number of cancer foci were the risk factors for the occurrence of CLNM in PTMC (P < 0.05); logistic regression analysis showed that gender, age, tumor diameter, perineural invasion, and multiple cancer foci were the risk factors for the occurrence of CLNM in PTMC (P < 0.05). Conclusion: Gender, age, ethnicity, body mass index, TSH value, tumor diameter, peritumoral invasion, microcalcified foci, number of cancer foci, and comorbidities can be used as predictive factors for quantitative risk assessment of the occurrence of CLNM in PTMC, which can provide a reference for further selection of suitable treatment options.
文章引用:张淼. 103例甲状腺微小乳头状癌中央淋巴结转移的预测因素分析[J]. 临床医学进展, 2024, 14(8): 1081-1086. https://doi.org/10.12677/acm.2024.1482323

参考文献

[1] Rahib, L., Smith, B.D., Aizenberg, R., Rosenzweig, A.B., Fleshman, J.M. and Matrisian, L.M. (2014) Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Research, 74, 2913-2921. [Google Scholar] [CrossRef] [PubMed]
[2] Roh, J., Kim, J. and Park, C.I. (2008) Central Cervical Nodal Metastasis from Papillary Thyroid Microcarcinoma: Pattern and Factors Predictive of Nodal Metastasis. Annals of Surgical Oncology, 15, 2482-2486. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, Q., Wang, Z., Meng, X., Duh, Q. and Chen, G. (2019) Predictors for Central Lymph Node Metastases in CN0 Papillary Thyroid Microcarcinoma (mptc): A Retrospective Analysis of 1304 Cases. Asian Journal of Surgery, 42, 571-576. [Google Scholar] [CrossRef] [PubMed]
[4] Miyauchi, A. (2016) Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid. World Journal of Surgery, 40, 516-522. [Google Scholar] [CrossRef] [PubMed]
[5] Miyauchi, A., Kudo, T., Ito, Y., Oda, H., Sasai, H., Higashiyama, T., et al. (2018) Estimation of the Lifetime Probability of Disease Progression of Papillary Microcarcinoma of the Thyroid during Active Surveillance. Surgery, 163, 48-52. [Google Scholar] [CrossRef] [PubMed]
[6] CATO中国抗癌协会甲状腺癌专业委员会. 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版) [J]. 中国肿瘤临床, 2016, 43(10): 405-411.
[7] 廖帅举, 刘晓丽, 倪卫惠, 陈晨, 王全胜. 94例甲状腺微小乳头状癌颈部淋巴结转移的影响因素分析[J]. 东南大学学报, 2022, 41(1): 132-137.
[8] So, Y.K., Kim, M., Kim, S. and Son, Y. (2018) Lateral Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis for Prevalence, Risk Factors, and Location. International Journal of Surgery, 50, 94-103. [Google Scholar] [CrossRef] [PubMed]
[9] 沈文亮, 吕晶, 黑虎, 等. cN0期甲状腺微小乳头状癌侧颈淋巴结转移危险因素分析[J]. 中国普通外科杂志, 2019, 28(5): 551-557.
[10] 曾书娥, 于姣姣, 耿霞飞. 甲状腺微小乳头状癌的超声特征与中央区淋巴结转移的危险因素分析[J]. 中国中西医结合影像学杂志, 2019, 17(5): 497-499.
[11] 王朝晖, 张悦嘉, 伏桂明, 等. 甲状腺微小乳头状癌中央区淋巴转移的危险因素分析[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(1): 12-17.
[12] Zane, M., Parello, C., Pennelli, G., Townsend, D.M., Merigliano, S., Boscaro, M., et al. (2017) Estrogen and Thyroid Cancer Is a Stem Affair: A Preliminary Study. Biomedicine & Pharmacotherapy, 85, 399-411. [Google Scholar] [CrossRef] [PubMed]
[13] 任婉丽, 李化静, 李宏慧, 等. 临床淋巴结阴性甲状腺微小乳头状癌患者中央区淋巴结转移危险因素分析[J]. 中国耳鼻咽喉颅底外科杂志, 2024, 30(3): 34-39.
[14] Cheng, F., Chen, Y., Zhu, L., Zhou, B., Xu, Y., Chen, Y., et al. (2019) Risk Factors for Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Single-Center Retrospective Study. International Journal of Endocrinology, 2019, Article ID: 8579828. [Google Scholar] [CrossRef] [PubMed]
[15] 张成雷. 可手术乳腺癌患者的循环肿瘤细胞与凝血功能及病理特征的关系研究[J]. 中国医学创新, 2019, 16(19): 62-65.
[16] 陈立权, 庞士勇, 丁士海, 等. 甲状腺微小乳头状癌颈淋巴结转移危险因素分析及外科处理策略[J]. 安徽医药, 2020, 24(5): 144-147.
[17] 杨乐, 马斌林. 1988例甲状腺微小乳头状癌症颈部中央区淋巴结转移危险因素分析[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(1): 52-57.